Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients

NCT02215798 · clinicaltrials.gov ↗

COMPLETED

Status

269

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: Cymbalta

Sponsor

Boehringer Ingelheim